-
1
-
-
0032731677
-
Management of the BPH syndrome in Germany: Who is treated and how?
-
Berges RR, Pientka L (1999) Management of the BPH syndrome in Germany: Who is treated and how? Eur Urol 36 [Suppl 3]: 21-27
-
(1999)
Eur Urol
, vol.36
, Issue.SUPPL. 3
, pp. 21-27
-
-
Berges, R.R.1
Pientka, L.2
-
2
-
-
0032746298
-
Introduction and concluding remarks
-
Chapple CR (1999) Introduction and concluding remarks. Eur Urol 36 [Suppl 3]: 1-6
-
(1999)
Eur Urol
, vol.36
, Issue.SUPPL. 3
, pp. 1-6
-
-
Chapple, C.R.1
-
3
-
-
0028921373
-
Stellenwert von phytotherapeutika bei der behandlung der benignen prostatahyperplasie (BPH)
-
Dreikorn K, Schönhöfer PS (1995) Stellenwert von Phytotherapeutika bei der Behandlung der benignen Prostatahyperplasie (BPH). Urologe A 34: 119-129
-
(1995)
Urologe A
, vol.34
, pp. 119-129
-
-
Dreikorn, K.1
Schönhöfer, P.S.2
-
4
-
-
0012398111
-
Other medical therapies
-
Chatelain C, Denis L, Foo KT, Khoury S, McConnell J (eds). Plymbridge Distributors, Plymouth
-
Dreikorn K, Lowe F, Borkowski A et al. (2001) Other medical therapies. In: Chatelain C, Denis L, Foo KT, Khoury S, McConnell J (eds) Proceedings of the 5th International Consultation on Benign Prostatic Hyperplasia (BPH). Plymbridge Distributors, Plymouth, pp 479-511
-
(2001)
Proceedings of the 5th International Consultation on Benign Prostatic Hyperplasia (BPH)
, pp. 479-511
-
-
Dreikorn, K.1
Lowe, F.2
Borkowski, A.3
-
5
-
-
0034256274
-
Phytotherapeutic agents in the treatment of benign prostatic hyperplasia
-
Dreikorn K (2000) Phytotherapeutic agents in the treatment of benign prostatic hyperplasia. Curr Urol Rep 1: 103-109
-
(2000)
Curr Urol Rep
, vol.1
, pp. 103-109
-
-
Dreikorn, K.1
-
6
-
-
0012367238
-
The medical management of BPH with agents oterh than hormones or alpha-blockers
-
Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds). Monaco, June 26-28 1995 S.C.I.
-
Fitzpatrick JM, Braeckman J, Denis L et al. (1996) The medical management of BPH with agents oterh than hormones or alpha-blockers. In: Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds) Proceedings of the 3rd International Consulation on benign prostatic hyperplasia (BPH). Monaco, June 26-28 1995 S.C.I. pp 489-494
-
(1996)
Proceedings of the 3rd International Consulation on Benign Prostatic Hyperplasia (BPH)
, pp. 489-494
-
-
Fitzpatrick, J.M.1
Braeckman, J.2
Denis, L.3
-
7
-
-
0000435965
-
Phytotherapeutic agents
-
Kirby R, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P (eds). Isis Medical Media, Oxford
-
Fitzpatrick JM, Lynch TH (1996) Phytotherapeutic agents. In: Kirby R, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P (eds) Textbook of Benign Prostatic Hyperplasia. Isis Medical Media, Oxford, pp 331-337
-
(1996)
Textbook of Benign Prostatic Hyperplasia
, pp. 331-337
-
-
Fitzpatrick, J.M.1
Lynch, T.H.2
-
8
-
-
0029859371
-
Serenoa repens (Permixon): A review of its Pharmacology and therapeutic efficacy in benign prostatic hyperplasia
-
Plosker GL, Brogden RN (1996) Serenoa repens (Permixon): A review of its Pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Drugs Aging 9: 379-395
-
(1996)
Drugs Aging
, vol.9
, pp. 379-395
-
-
Plosker, G.L.1
Brogden, R.N.2
-
9
-
-
0012402270
-
Analytische charakterisierung von sabalextrakten und sabalzubereitungen in Europa und in USA
-
18-19.05. Bad Neuenaar
-
Kurth H, Glasmacher F, Gaedcke F (2000) Analytische Charakterisierung von Sabalextrakten und Sabalzubereitungen in Europa und in USA. 3. Finzelbergsymposium, 18-19.05. Bad Neuenaar
-
(2000)
Finzelbergsymposium
, vol.3
-
-
Kurth, H.1
Glasmacher, F.2
Gaedcke, F.3
-
10
-
-
0029066391
-
Placebo-controlled evaluation of the efficacy and tolerability of Permixon in benign prostatic hyperplasia after exclusion of placebo responders
-
Descotes JL, Rambeaud JJ, Deschaseaux P, Faure G (1996) Placebo-controlled evaluation of the efficacy and tolerability of Permixon in benign prostatic hyperplasia after exclusion of placebo responders. Clin Drug Invest 9: 291-297
-
(1996)
Clin Drug Invest
, vol.9
, pp. 291-297
-
-
Descotes, J.L.1
Rambeaud, J.J.2
Deschaseaux, P.3
Faure, G.4
-
11
-
-
0012435601
-
Randomized, double blind, placebo-controlled study of saw palmetto in men with lower urinary tract symtoms (LUTS)
-
Kuznetsow DD, Gerber GS, Burstein JD (2001) Randomized, double blind, placebo-controlled study of saw palmetto in men with lower urinary tract symtoms (LUTS). J Urol 165: 263
-
(2001)
J Urol
, vol.165
, pp. 263
-
-
Kuznetsow, D.D.1
Gerber, G.S.2
Burstein, J.D.3
-
12
-
-
0347318854
-
Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostatic hyperplasia: A randomized international study of 1.089 patients
-
Carraro JC, Raynaud JP, Koch G et al. (1996) Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostatic hyperplasia: a randomized international study of 1.089 patients. Prostate 29: 231-240
-
(1996)
Prostate
, vol.29
, pp. 231-240
-
-
Carraro, J.C.1
Raynaud, J.P.2
Koch, G.3
-
13
-
-
0012470488
-
Phytotherapy (LSESR) vs an αblocker for treatment of lower urinary tract symptoms secondary to benign prostatic enlargement: A randomized comparative study
-
Debruyne F (2001) Phytotherapy (LSESR) vs an αblocker for treatment of lower urinary tract symptoms secondary to benign prostatic enlargement: A randomized comparative study. J Urol 165 (5): 381-382
-
(2001)
J Urol
, vol.165
, Issue.5
, pp. 381-382
-
-
Debruyne, F.1
-
14
-
-
0029078027
-
Randomised, placebo-controlled, double blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia
-
Berges RR, Windeler J, Trampisch H et al. (1995) Randomised, placebo-controlled, double blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Lancet 345: 1529-1532
-
(1995)
Lancet
, vol.345
, pp. 1529-1532
-
-
Berges, R.R.1
Windeler, J.2
Trampisch, H.3
-
15
-
-
0034052168
-
Treatment of symptomatic benign prostatic hyperplasia with â-sitosterol: An 18-month follow-up
-
Berges RR, Kassen A, Senge T (2000) Treatment of symptomatic benign prostatic hyperplasia with â-sitosterol: an 18-month follow-up. BJU Int 85: 842-846
-
(2000)
BJU Int
, vol.85
, pp. 842-846
-
-
Berges, R.R.1
Kassen, A.2
Senge, T.3
-
16
-
-
0031398916
-
A multicentric, placebo-controlled, double-blind clinical trial of β-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia
-
Klippel KF, Hiltl D-M, Schipp B (1997) A multicentric, placebo-controlled, double-blind clinical trial of β-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. Br J Urol 80: 427-432
-
(1997)
Br J Urol
, vol.80
, pp. 427-432
-
-
Klippel, K.F.1
Hiltl, D.-M.2
Schipp, B.3
-
17
-
-
0031671309
-
Efficacy and acceptability of Tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): A multicentre trial in Central Europe
-
Breza J, Dziurny O, Borowka A, et al (1998) Efficacy and acceptability of Tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): A multicentre trial in Central Europe. Curr Med Res Opin 3: 127-139
-
(1998)
Curr Med Res Opin
, vol.3
, pp. 127-139
-
-
Breza, J.1
Dziurny, O.2
Borowka, A.3
-
18
-
-
0033119883
-
Phytotherapyin the treatment of benign prostatic hyperplasia: An update
-
Lowe FC, Fagelman E (1999) Phytotherapyin the treatment of benign prostatic hyperplasia: an update. Urology 53: 671-678
-
(1999)
Urology
, vol.53
, pp. 671-678
-
-
Lowe, F.C.1
Fagelman, E.2
-
19
-
-
0030430231
-
Phytotherapy for the prostate
-
Buck AC (1996) Phytotherapy for the prostate. Br J Urol 78: 325-336
-
(1996)
Br J Urol
, vol.78
, pp. 325-336
-
-
Buck, A.C.1
-
20
-
-
0002229222
-
Phytotherapie der benignen prostatahyperplasie: Doppelblindstudie mit extractum radicis urticae (ERU)
-
Dathe G, Schmid H (1987) Phytotherapie der benignen Prostatahyperplasie: Doppelblindstudie mit Extractum Radicis Urticae (ERU). Urologe B 27: 233-226
-
(1987)
Urologe B
, vol.27
, pp. 233-226
-
-
Dathe, G.1
Schmid, H.2
-
21
-
-
0021919879
-
Ergebnisse einer doppelblindstudie über die wirksamkeit von ERU-Kapseln in der konservativen behandlung der benignen prostatahyperplasie
-
Vontobel HP, Herzog R, Rutishauser GH (1985) Ergebnisse einer Doppelblindstudie über die Wirksamkeit von ERU-Kapseln in der konservativen Behandlung der benignen Prostatahyperplasie. Urologe A 24: 49-51
-
(1985)
Urologe A
, vol.24
, pp. 49-51
-
-
Vontobel, H.P.1
Herzog, R.2
Rutishauser, G.H.3
-
22
-
-
0029815804
-
Therapie der benignen prostatahyperplasie mit bazoton liquidum
-
Engelmann U, Boos G, Kres H (1996) Therapie der benignen Prostatahyperplasie mit Bazoton Liquidum. Urologe B 36: 287-291
-
(1996)
Urologe B
, vol.36
, pp. 287-291
-
-
Engelmann, U.1
Boos, G.2
Kres, H.3
-
23
-
-
0023691102
-
Konservative therapie der benignen prostatahyperplasie (BPH) mit cernilton
-
Becker H, Ebeling L (1988) Konservative Therapie der benignen Prostatahyperplasie (BPH) mit Cernilton. Urologe B 28: 301-306
-
(1988)
Urologe B
, vol.28
, pp. 301-306
-
-
Becker, H.1
Ebeling, L.2
-
24
-
-
0025119848
-
Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract Cernilton
-
Buck AC, Cox R, Rees RWM et al. (1990) Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract Cernilton. Br J Urol 66: 398-404
-
(1990)
Br J Urol
, vol.66
, pp. 398-404
-
-
Buck, A.C.1
Cox, R.2
Rees, R.W.M.3
-
25
-
-
0029984815
-
Usefulness of Cernilton in the treatment of benign prostatic hyperplasia
-
Dutkiewicz S (1996) Usefulness of Cernilton in the treatment of benign prostatic hyperplasia. Int Urol Nephrol 28: 49-53
-
(1996)
Int Urol Nephrol
, vol.28
, pp. 49-53
-
-
Dutkiewicz, S.1
-
26
-
-
0033789446
-
Placebokontrollierte langzeittherapiestudie mit kürbissamenextrakt bei BPH-bedingten miktionsbeschwerden
-
Bach D (2000) Placebokontrollierte Langzeittherapiestudie mit Kürbissamenextrakt bei BPH-bedingten Miktionsbeschwerden. Urologe B 40: 437-443
-
(2000)
Urologe B
, vol.40
, pp. 437-443
-
-
Bach, D.1
-
27
-
-
0025603727
-
Treatment of benign prostatic hyperplasia with phytosterols
-
Carbin BE, Larsson B, Lindahl O (1990) Treatment of benign prostatic hyperplasia with phytosterols. Br J Urol 66: 639-641
-
(1990)
Br J Urol
, vol.66
, pp. 639-641
-
-
Carbin, B.E.1
Larsson, B.2
Lindahl, O.3
-
28
-
-
0029842385
-
Wirksamkeit eines sabal-urtica-kombinationspräparates bei der behandlung der benignen prostatahyperplasie (BPH)
-
Metzker M, Kieser M, Hölscher U (1996) Wirksamkeit eines Sabal-Urtica-Kombinationspräparates bei der Behandlung der benignen Prostatahyperplasie (BPH). Urologe B 36: 292-300
-
(1996)
Urologe B
, vol.36
, pp. 292-300
-
-
Metzker, M.1
Kieser, M.2
Hölscher, U.3
-
29
-
-
0030805911
-
Kombination aus sabalund urticaextrakt mit finasterid bei BPH (Stad.bis II nach Alken)
-
Sökeland J, Albrecht J (1997) Kombination aus Sabalund Urticaextrakt mit Finasterid bei BPH (Stad.bis II nach Alken). Urologe A 36: 327-333
-
(1997)
Urologe A
, vol.36
, pp. 327-333
-
-
Sökeland, J.1
Albrecht, J.2
-
30
-
-
1842376945
-
Discrepancies between meta-analyses and subsequent large randomised, controlled trials
-
LeLorier J, Grégoire G, Benhaddad A et al. (1997) Discrepancies between meta-analyses and subsequent large randomised, controlled trials. N Engl J Med 337: 536-542
-
(1997)
N Engl J Med
, vol.337
, pp. 536-542
-
-
LeLorier, J.1
Grégoire, G.2
Benhaddad, A.3
-
31
-
-
0034058050
-
Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia
-
Boyle P, Lowe F, Robertson C, Roehrborn CG (2000) Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology 55: 533-539
-
(2000)
Urology
, vol.55
, pp. 533-539
-
-
Boyle, P.1
Lowe, F.2
Robertson, C.3
Roehrborn, C.G.4
-
32
-
-
0032508943
-
Saw palmetto extracts for treatment of benign prostatic hyperplasia: A systematic review
-
Wilt TJ, Ishani A, Stark G et al. (1998) Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 280: 1604-1609
-
(1998)
JAMA
, vol.280
, pp. 1604-1609
-
-
Wilt, T.J.1
Ishani, A.2
Stark, G.3
-
33
-
-
0033049121
-
â-sitosterol for the treatment of benign prostatic hyperplasia: A systematic review
-
Wilt TJ, McDonald R, Ishani A (1999) â-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU Int 83: 976-983
-
(1999)
BJU Int
, vol.83
, pp. 976-983
-
-
Wilt, T.J.1
McDonald, R.2
Ishani, A.3
-
34
-
-
0034052603
-
Asystematic review of Cernilton for the treatment of benign prostatic hyperplasia
-
MacDonald R, Ishani A, Rutks I et al. (2000) Asystematic review of Cernilton for the treatment of benign prostatic hyperplasia. BJU Int 85: 836-841
-
(2000)
BJU Int
, vol.85
, pp. 836-841
-
-
MacDonald, R.1
Ishani, A.2
Rutks, I.3
-
35
-
-
0034563896
-
Pygeum Africanum for the treatment of patients with benign prostatic hyperplasia: A systematic review and quantitative metaanalysis
-
Ishani A, MacDonald R, Nelson D, Rutks I, Wilt TJ (2000) Pygeum Africanum for the treatment of patients with benign prostatic hyperplasia: A systematic review and quantitative metaanalysis. Am J Med 109: 654-664
-
(2000)
Am J Med
, vol.109
, pp. 654-664
-
-
Ishani, A.1
MacDonald, R.2
Nelson, D.3
Rutks, I.4
Wilt, T.J.5
-
36
-
-
0036549740
-
The role of phytotherapy in treating lower urinary tract symptoms and benign prostetic hyperplasia
-
Dreikorn K (2002) The role of phytotherapy in treating lower urinary tract symptoms and benign prostetic hyperplasia. World J Urol 19: 426-435
-
(2002)
World J Urol
, vol.19
, pp. 426-435
-
-
Dreikorn, K.1
|